News
Panel is capable of detecting 99.99% of all currently identified SARS-CoV-2 viruses based on sequence alignments and in silico analysis LEXINGTON, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- T2 ...
T2 Biosystems T2SARS-CoV-2™ Panel Proves Capable of Detecting the Mu B.1.621 and Iota B.1.526 Variants of the SARS-CoV-2 Virus T2 Biosystems, Inc. Thu, Sep 9, 2021, 4:52 PM 5 min read ...
--T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2™ Panel— a molecular diagnostic test that detects SARS-CoV-2, the virus ...
LEXINGTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today ...
LEXINGTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today ...
--T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2™ Panel— a molecular diagnostic test that detects SARS-CoV-2, the virus ...
Panel can detect multiple variants of the SARS-CoV-2 virus, including those most recently identified in the United Kingdom, South Africa, and the U.S. LEXINGTON, Mass., Jan. 11, 2021 (GLOBE ...
LEXINGTON, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2™ Panel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback